Journal profile · Medicine-Epidemiology
Clinical Epidemiology
ISSN 1179-1349 · Dove Medical Press Ltd. · NEW ZEALAND
Clinical Epidemiology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.25; JCR Q1 (journal website); fully open access; APC about USD 3,940; median 115 days to acceptance (104 articles, last 24 months); acceptance rate 6% (journal website); 92 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Clinical Epidemiology is published by Dove Medical Press Ltd. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Global Cancer Incidence and Screening, Chronic Disease Management Strategies and Medical Coding and Health Information, together about 22.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Editor-in-Chief: Professor Henrik Toft Sorensen Clinical Epidemiology is an international, peer reviewed, open access journal. Clinical Epidemiology is primarily focused on research on clinical questions, and on the application of epidemiological principles and questions relating to patients and clinical care in terms of prevention, diagnosis, prognosis, and treatment. All meta-analyses require a pre-submission check prior to submitting to Clinical Epidemiology. Please complete the pre-submission check form here. Specific topics covered in the journal include: Use of electronic medical patient records Routine health care data, especially as applied to the safety of medical interventions Clinical utility of diagnostic procedures and screening Understanding short- and long-term clinical course of diseases Prognostic and predictive markers Clinical epidemiological and biostatistical methods Systematic reviews Secondary and tertiary prevention Clinical Epidemiology welcomes papers covering these topics in the form of original research, reviews, and descriptions of international databases. When considering submission of a paper utilizing publicly available data, authors should ensure that such studies add significantly to the body of knowledge and that they use appropriate validated methods for exposures and health outcomes. Updated 12 August 2025
From the journal's Aims & Scope
Research area (LetPub): Medicine-Epidemiology
Editor-in-chief Henrik ToftPublisher website
Editorial board by country: 2 in mainland China (about 3%); most named United States 17, United Kingdom 10, Denmark 7, Netherlands 4, Russia 4 (60 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Global Cancer Incidence and ScreeningMedicine8.8%
- Chronic Disease Management StrategiesMedicine7.8%
- Medical Coding and Health InformationHealth Professions5.7%
- Colorectal Cancer Screening and DetectionMedicine5.5%
- Advanced Causal Inference TechniquesMathematics5.5%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine5.2%
- Sepsis Diagnosis and TreatmentMedicine4.4%
- Acute Myocardial Infarction ResearchMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Public, Environmental & Occupational Health | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Public, Environmental & Occupational Health | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Public, Environmental & Occupational Health | Zone 2 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q1 · best quartile · 2025
- CiteScore Q1 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.25LetPub ·
- Impact factor (publisher) 2025
- 4.8Publisher website ·
- 5-year impact factor (publisher)
- 6.7Publisher website ·
- CiteScore 2026-06
- 6.7LetPub ·
- CiteScore (publisher) 2025
- 1.77Publisher website ·
- SJR 2026-06
- 1.66LetPub ·
- SNIP 2026-06
- 1.77LetPub ·
- h-index
- 49LetPub ·
- h-index
- 103OpenAlex ·
- i10-index
- 903OpenAlex ·
- 2-year mean citedness
- 4.09OpenAlex ·
- Self-citation rate
- 4.7%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 83LetPub ·
- Downloads per year (publisher)
- 189,072Publisher website ·
Articles by year OpenAlex count · 1,497 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 73 | 73 | 16 |
| 2025 | 92 | 92 | 311 |
| 2024 | 82 | 82 | 682 |
| 2023 | 105 | 105 | 1,215 |
| 2022 | 138 | 138 | 2,143 |
| 2021 | 108 | 108 | 2,928 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
115 daysMedian, submission to acceptance · P25–P75 92 days – 151 days
- Acceptance to online
- median 21 days (104 articles)
- Submission to online
- median 139 days
- Sample
- 104 articles with submission and acceptance dates (185 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 16 weeksLetPub ·
- Acceptance rate (publisher)
- 6%Publisher website ·
- Desk decision
- 58 daysPublisher website ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,940 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 2,836 | — | — | |
| LetPub | USD 3,300 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted2
- case reportAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
- reviewAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
Policy excerpts from the journal's websitePublication ethics, Peer review
- Publication ethics
Member of and subscribes to the principles of the Committee on Publication Ethics (COPE) Model summary
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Source ↗Publisher website ·- Peer review
Endorses CONSORT, PRISMA, STROBE, and RECORD-PE reporting statements Model summary
Clinical Epidemiology endorses the CONSORT statement for reporting clinical trials, the PRISMA statement for the reporting of systematic reviews and meta-analyses, the STROBE statement for the reporting of epidemiological studies, and the RECORD statement for the Reporting of Studies Conducted Using Observational Routinely Collected Health Data Statement for Pharmacoepidemiology (RECORD-PE).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Dove Medical Press Ltd.
- Country or region
- NEW ZEALAND
- Language
- English
- ISSN
- 1179-1349
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Clinical Epidemiology
What CAS zone is Clinical Epidemiology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Clinical Epidemiology is in Zone 3 of Medicine, and in Zone 2 of the minor category Public, Environmental & Occupational Health. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Clinical Epidemiology?
The latest impact factor listed by LetPub is 4.25; CiteScore 6.7, h-index 103.
How long does peer review take at Clinical Epidemiology?
Based on the dates recorded on 104 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 115 days (interquartile range 92–151 days); authors report an average review time of about 16 weeks; the journal's website gives an acceptance rate of 6%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Clinical Epidemiology in?
The journal's website gives JCR Q1 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 3 of Medicine.
Where are the editorial board members of Clinical Epidemiology based?
Of the 60 board members whose country the journal's board page names, 2 (about 3%) are in mainland China; the countries named most often are United States (17), United Kingdom (10) and Denmark (7). Counted from the institutions listed on the board page; for reference only.
Which databases index Clinical Epidemiology?
According to LetPub and DOAJ records, Clinical Epidemiology is indexed in SCIE, Scopus and DOAJ.
Is Clinical Epidemiology open access, and what is the APC?
Clinical Epidemiology is a fully open-access journal. APC about USD 3,940.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .